ciprofloxacin has been researched along with Erysipelas in 2 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Erysipelas: An acute infection of the skin caused by species of STREPTOCOCCUS. This disease most frequently affects infants, young children, and the elderly. Characteristics include pink-to-red lesions that spread rapidly and are warm to the touch. The commonest site of involvement is the face.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ciprofloxacin in a low dosage of 250 mg twice a day was applied in the treatment of bacterial infections of the skin." | 3.67 | [The effectiveness of ciprofloxacin in bacterial skin infections]. ( Blenk, H; Meisel, C, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bousquet, A | 1 |
| Demoures, T | 1 |
| Malfuson, JV | 1 |
| Martinaud, C | 1 |
| Soler, C | 1 |
| Meisel, C | 1 |
| Blenk, H | 1 |
2 other studies available for ciprofloxacin and Erysipelas
| Article | Year |
|---|---|
Campylobacter jejuni cutaneous infection in a patient with graft versus host disease.
Topics: Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Erysipelas; Graft vs Host Disease; He | 2012 |
[The effectiveness of ciprofloxacin in bacterial skin infections].
Topics: Administration, Oral; Bacterial Infections; Ciprofloxacin; Drug Administration Schedule; Erysipelas; | 1988 |